The Safety of Available Immunotherapy for the Treatment of Glioblastoma

INTRODUCTION: Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Current standard of care involves maximal surgical resection combined with adjuvant chemoradiation. Growing support exists for a role of immunotherapy in treating these tumors with the goal of targeted cytot...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Expert Opin Drug Saf
Main Authors: Farber, S. Harrison, Elsamadicy, Aladine A., Atik, Fatih, Suryadevara, Carter M., Chongsathidkiet, Pakawat, Fecci, Peter E., Sampson, John H.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404815/
https://ncbi.nlm.nih.gov/pubmed/27989218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1273898
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki